PharmaHub · Other Pharma & Biotech · North America

Us External Ventricular Drain Market Size, Share Outlook, Growth Analysis Report and Forecast Trends 2026-2030

External ventricular drains (EVDs) are sterile, pressure-monitored catheter systems used by neurosurgeons and critical care physicians to drain excess cerebrospinal fluid and manage elevated intracranial pressure in patients with traumatic brain injury, stroke, hydrocephalus, and related conditions. The North American EVD market is valued at approximately $1.749 billion in 2026 and is growing at a 9.3% compound annual growth rate, reflecting rising procedure volumes and technology upgrades. The United States accounts for the largest regional share, driven by a high density of Level I trauma centers, advanced hospital infrastructure, and strong healthcare spending. Continued innovation in catheter materials and integrated monitoring technology, combined with an aging population and growing neuro-critical care awareness, is expected to sustain robust market expansion through 2031.

Market size · 2026
$1.7 billion
CAGR · 2026–2031
9.3%
Forecast · 2031
$2.7 billion
Basis
Claight Analysis
Market size (USD)
Base year 2026
Official data · Claight AnalysisForecast
Market size and forecast are Claight Analysis, informed by public research.
Forecast
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2026 base: $1.7bn2031 est: $2.7bn
Read the full Us External Ventricular Drain Market Report report →

Market Overview

External ventricular drain systems are sterile, pressure-monitoring catheter assemblies implanted to manage intracranial pressure in patients with traumatic brain injury, subarachnoid hemorrhage, hydrocephalus, and other serious neurological conditions. The North American market for these neuro-critical care devices reached approximately $1.749 billion in 2026, building on prior-year growth and positioned for continued expansion at a 9.3% annual rate. The product category encompasses standard drainage catheters, integrated digital pressure-monitoring systems, and specialized acute-use configurations designed for intensive care unit environments.

  • EVD systems are sterile, pressure-monitoring catheter assemblies used to manage intracranial pressure in neurological patients
  • The North American market was valued at approximately $1.749 billion in 2026 and is growing at a 9.3% annual rate
  • The product category spans standard drainage catheters, integrated monitoring systems, and specialized acute-use configurations

Growth Drivers

The market is propelled by a combination of epidemiological, technological, and healthcare-system factors that collectively increase both the volume and complexity of EVD procedures across North America. An aging demographic, rising prevalence of cerebrovascular diseases, and greater awareness of the clinical importance of intracranial pressure monitoring in trauma and critical care settings are expanding the patient pool requiring these interventions. Concurrently, advances in catheter design, anti-siphon mechanisms, and integrated sensor technology are encouraging hospitals to upgrade existing equipment and adopt higher-value product variants.

  • Aging demographic and rising prevalence of cerebrovascular diseases expanding the patient pool requiring EVD procedures
  • Technological advances in catheter design, anti-siphon mechanisms, and digital pressure sensors driving product upgrades
  • Growing adoption of intracranial pressure monitoring in trauma and critical care settings increasing procedural volumes
Want a deeper cut on Us External Ventricular Drain Market Report? We build bespoke studies on request.
Connect to an analyst →

Segmentation and Regional Analysis

The North American EVD market is segmented by product type, including standard drainage catheters, integrated pressure-monitoring systems with digital transducers, and specialized acute or chronic drainage configurations. End users span tertiary hospitals, specialized neurosurgical centers, and long-term care facilities, with demand driven by procedure volume, ICU bed availability, and institutional neuro-critical care capability. The United States dominates regional revenue, supported by higher per-capita healthcare expenditure, a greater density of Level I trauma centers, and broader reimbursement coverage relative to Canada.

  • Product segments include standard drainage catheters, integrated pressure-monitoring systems, and acute and chronic configurations
  • End users span tertiary hospitals, neurosurgical centers, and long-term care facilities across the region
  • The U.S. accounts for the dominant share of regional revenue while North American growth of 9.3% reflects expanding procedural volumes

Competitive Landscape

Who are the notable companies in the industry?

The market structure is moderately fragmented, with a mix of large diversified medical device manufacturers that carry broad neurosurgical portfolios and smaller specialty producers focused primarily on neuro-critical care drainage products. Producers range from vertically integrated companies with in-house catheter extrusion, sensor fabrication, and monitoring-system assembly capabilities to focused specialty firms that emphasize proprietary catheter-tip designs, anti-siphon valve technology, or closed-drainage system architecture. Technology pathways center on silicone or polyurethane lumen extrusion, pressure-transducer miniaturization, and closed-system fluid-management designs, with manufacturing and R&D capacity concentrated in regions that offer advanced medical device infrastructure and regulatory proximity to major North American healthcare markets.

  • Moderately fragmented market with a mix of large diversified medical device manufacturers and specialty neuro-critical care producers
  • Technology pathways center on silicone and polyurethane catheter extrusion, pressure-transducer miniaturization, and closed-system fluid management
  • Manufacturing and R&D capacity concentrated in regions with advanced medical device infrastructure and regulatory proximity to major North American markets

Trends and Outlook

What are the recent trends and outlook?

Emerging product trends point toward wireless or Bluetooth-enabled pressure monitoring, antimicrobial catheter coatings to reduce ventriculitis risk, and integrated EVD systems that consolidate drainage, continuous measurement, and electronic health record data into a single connected platform. These innovations are expected to improve clinical outcomes, reduce hospital-acquired infection rates, and support the broader shift toward digital neuro-critical care workflows, potentially accelerating replacement-cycle demand for hospitals upgrading legacy equipment. Long-term market growth will likely be sustained by rising disease burden, continued pipeline introductions of advanced catheter technologies, and expanding use of EVDs in new procedural applications, keeping the North American market on a trajectory toward substantially larger valuations through 2031 and beyond.

  • Wireless pressure monitoring, antimicrobial coatings, and integrated digital platforms are emerging product directions
  • Infection prevention and EHR integration are expected to accelerate replacement-cycle demand for advanced drainage systems
  • Long-term growth sustained by rising disease burden, new catheter technologies, and expanding procedural applications through the decade
Talk to a Claight analyst
Do you want to research Us External Ventricular Drain Market Report?

Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.

Connect to an analyst →

Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2026 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.